logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
P

PULMONARY PHARMACOLOGY & THERAPEUTICS

IF2.8
Papers28
Citations
Journal Papers 28
Publication Date
delete
Cellular Senescence and Vascular Ageing in Pulmonary Hypertension: Molecular Mechanisms, Therapeutic Strategies, and Translational Endpoints
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-10-23
delete0
PREAI
deleteYide Chen; Xiaolan Wang; Meng Gao; Qinei Zheng; Qianyue Zhang; Ting Liu; Shuanglan Xu; Jiao Yang; Xiqian Xing
deleteShare
deleteSave
Pharmacological Enhancement of O-GlcNAcylation Attenuates Lung Ischemia-Reperfusion Injury
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-10-17
delete0
PREAI
deleteYang Jin; Yu Fu; Nan Zhang; Xuemei Jiang; Jiameng Gao; Zhiyuan Zhang; Xiaotong Huang; Maojun Zhou; Chang Chen; Zongmei Wen
deleteShare
deleteSave
First-in-Human Safety and Pharmacokinetic Evaluation of Seralutinib, an Investigational Inhaled Tyrosine-protein Kinase Inhibitor for Pulmonary Hypertension
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-10-13
delete0
PREAI
deleteJianke Li; Lawrence S. Zisman; Matt Cravets; Richard Aranda
deleteShare
deleteSave
Belumosudil Improves Experimental Pulmonary Fibrosis via the ROCK2/Smad3/CTGF Pathway
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-10-01
delete0
PREAI
deleteDexin Kong; Guanghua Zhang; Zhonghong Jiang; Wanglin Jiang
deleteShare
deleteSave
Steroid-sparing strategies in respiratory diseases: efficacy and safety of current therapeutic options
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-09-23
delete0
PREAI
deleteMateusz Gadzała; Aleksandra Paź; Dagmara Mirowska-Guzel
deleteShare
deleteSave
Targeting pulmonary and arterial chemoreceptors via inhaled therapeutics: A novel pathway to blunt hypoxia-induced pulmonary hypertension?
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-09-23
delete0
PREAI
deleteDurlav Chowdhury; Surendra H. Bodakhe
deleteShare
deleteSave
TNF-α–mediated molecular switching links COPD to lung cancer: Integrated in silico and in vivo study of oxidative stress–driven disease transition
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-09-06
delete0
PREAI
deleteRiya Manna; Jagannath Das; Debraj Roy; Sampurna Bhattacharya; Sudipto Saha; Runa Sur; I.B. Chatterjee; Rajat Banerjee
deleteShare
deleteSave
The preclinical discovery and development of depemokimab for severe eosinophilic asthma
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-09-01
delete1
PREAI
deleteCazzola, Mario; Patella, Vincenzo; Pagliaro, Raffaella; Bianco, Andrea; Rogliani, Paola; Matera, Maria Gabriella
deleteShare
deleteSave
Efficacy and safety of magnesium glycinate as add on therapy in hypomagnesemic asthma and chronic obstructive pulmonary disease patients: A randomised controlled study assessing inflammatory biomarkers
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-08-23
delete0
PREAI
deleteManeesh Kumar Maddirevula; Muhasaparur G. Rajanandh; Boman Wesley
deleteShare
deleteSave
m6A reader IGF2BP2 mediates airway remodeling by stabilizing Dixdc1 in asthma pathogenesis
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-08-01
delete0
PREAI
deleteLi, Xiao-Mang; Mo, Bi-Wen; Gao, Yan; Chen, Yun-Xiang; Xiao, Bo; Gu, Yue; Liang, Miao-Miao; Li, Hui-Min
deleteShare
deleteSave
Real-life application of the optical beta-adrenergic sweat test for people with cystic fibrosis
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-07-17
delete0
PREAI
deleteKarina Kleinfelder; Anca Manuela Hristodor; Giorgio Centin; Antonella Casiraghi; Paola Minghetti; Emily Pintani; Marina Bertini; Claudio Sorio; Paola Melotti
deleteShare
deleteSave
Effects of anumigilimab, an anti–G-CSF receptor mAb, after segmental LPS challenge: A Phase 1b trial in healthy volunteers
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-07-06
delete0
deleteOAAI
deleteJens M. Hohlfeld; Meike Müller; Philipp Badorrek; Laurent B. Nicolas; Oliver Vit; William G. Darby; Judith Field; Michael Larbig
deleteShare
deleteSave
Methodological considerations on the effectiveness of biologics in asthma-COPD overlap
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-07-01
delete0
PREAI
deleteLiu, Tingfang; Jian, Ye
deleteShare
deleteSave
Brain-derived neurotrophic factor (BDNF) signaling in respiratory disease: Mechanisms, neuroimmune crosstalk, and therapeutic implications
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-07-01
delete0
PREAI
deleteEntesar Yaseen Abdo Qaid; Idris Long
deleteShare
deleteSave
TROP2 as a Promising Therapeutic Target in Lung Cancer: Current Clinical Trial Landscape and Future Directions
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-06-09
delete0
PREAI
deleteMaosen Liu; Ruihang Luo; Yichen Liu; Yuxin Fan; Jingtao Zhang; Mingshan Liu
deleteShare
deleteSave
PD05, a novel neutrophil elastase inhibitor, mitigates LPS-induced acute lung injury in a preclinical model
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-06-01
delete0
PREAI
deleteSingh, Sabita; Jaiswal, Ashish; Dutta, Joytri; Ray, Archita; Sengupta, Sayantan; Dey, Sudip; Bandyopadhyay, Arun; Jaisankar, Parasuraman; Mabalirajan, Ulaganathan
deleteShare
deleteSave
Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-05-05
delete0
PREAI
deleteHaidi Sun; Li Han; Hongwei Wu; Hongsheng Xue; Ming-Fei Lang; Jingyu Tan
deleteShare
deleteSave
Evodiamine protects against lung ischemia–reperfusion injury by attenuating SYK-associated TLR4/NLRP3 inflammasome activation and ferroptosis-related injury signatures
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-04-06
delete0
PREAI
deleteWei Peng; Baiping Ge; Rui Zhang; Yunen Liu; Changci Tong; Chenguang Dong
deleteShare
deleteSave
Evaluation of the effect of modulator therapies on medication complexity in adult cystic fibrosis patients
deletePULMONARY PHARMACOLOGY & THERAPEUTICS
IF2.8
delete2026-03-10
delete0
PREAI
deleteEsen Deniz Akman Ar; Nadir Yalçın; Uğur Balaban; Oğuz Karcıoğlu; Ebru Damadoğlu; Ali Fuat Kalyoncu; Kutay Demirkan
deleteShare
deleteSave
Nicotinamide N-oxide alleviates sepsis-induced acute lung injury by inhibiting ferroptosis through activation of the SIRT1/AKT signalling pathway
deletePulmonary Pharmacology & Therapeutics
IF2.8
delete2026-03-05
delete0
PREAI
deleteShujuan Liu; Mian Fu; Xiguang Liu; Yichen Jin; Liwen Fan; Qingyan Ni; Zihan Xu; Yusa Li; Jiawen Zhou; Huizhen Chen
deleteShare
deleteSave